Olema Pharmaceuticals Inc... (OLMA)
NASDAQ: OLMA
· Real-Time Price · USD
9.60
-0.77 (-7.43%)
At close: Oct 16, 2025, 3:59 PM
9.48
-1.25%
After-hours: Oct 16, 2025, 07:43 PM EDT
-7.43% (1D)
| Bid | 9.26 |
| Market Cap | 658.89M |
| Revenue (ttm) | 364K |
| Net Income (ttm) | -142.29M |
| EPS (ttm) | -1.97 |
| PE Ratio (ttm) | -4.87 |
| Forward PE | -4.95 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10 |
| Volume | 1,932,948 |
| Avg. Volume (20D) | 910,092 |
| Open | 10.54 |
| Previous Close | 10.37 |
| Day's Range | 9.58 - 10.76 |
| 52-Week Range | 2.86 - 13.51 |
| Beta | 2.09 |
| Ex-Dividend Date | n/a |
About OLMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OLMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OLMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+16.19%
Olema Pharmaceuticals shares are trading higher. T...
Unlock content with
Pro Subscription
10 months ago
+0.89%
Olema Pharmaceutical shares are trading higher after the company announced a new clinical trial collaboration and supply agreement with Novartis for frontline metastatic breast cancer. Also, the company entered into a private placement of common stock worth $250 million.
